공지사항

Multiple Myeloma and csx transportation Reactive Airway disease Transportation

According to the lawsuit, Peter worked for the Long Island Railroad Company (LIRR) for 29 years, and during that time he was exposed to numerous hazardous chemicals. These chemicals and substances included diesel fumes creosote fumes, welding fumes and dust.

Multiple myeloma affects the plasma cells, which produce antibodies to fight diseases and infections. These cancerous cells form tumors in the bones called plasmacytomas.

Symptoms

The cancer affects plasma cells, which make antibodies that help the body fight infections and germs. The symptoms of multiple myeloma are back pain and the ribs, brittle bones that break easily, weakness, fatigue loss of appetite as well as kidney problems.

Often, myeloma is not able to cause symptoms until its early stages. A doctor may not discover it until the routine urine or blood test for a different condition results in higher levels of protein than normal. This is known as smoldering myeloma. Myeloma may cause damage to organs such as the kidneys, lung or nervous system in later stages. It can cause vision and balance problems.

Your outlook is influenced by the stage of your myeloma and other health conditions as well as your age at diagnosis. Your outlook also depends on the number of plasma cells that develop tumors and cause complications, as do genetic factors that influence the likelihood of developing myeloma.

People who have a chromosomal anomaly, also called deletion 17p, or duplication 18q, have a poorer prospects than those who don't have these anomalies. If your kidneys do not perform as well, you'll have a poorer prospect of survival. The amount of creatinine in your blood is an excellent indicator of how well your kidneys work.

Diagnosis

Multiple myeloma gets diagnosed when the patient's urine or blood is analyzed for another illness and an over-the-top amount of protein is identified. Symptoms of myeloma include bone pain; weakness of the bones, including the back and ribs kidney problems or a fever that has no known reason; bruising or bleeding frequently; and difficulty breathing.

The condition is more prevalent among people over the age of 60 and is most often seen in males over 60. Myeloma is more common in people with relatives of the first degree. Their risk of getting the disease is 2 to 3 times greater than other people. This includes parents and siblings as well as children.

Many risk factors for myeloma have been identified. A previous diagnosis of extramedullary or solitary bone plasmacytoma (such as a throat or lung) is one of these risk factors. Myeloma tends to be more prevalent among those who have been exposed either to radiation or chemicals such as asbestos, pesticides and benzene. People who have an elevated level of monoclonal-gammopathy of unknown significance (MGUS) in the blood are more at risk of developing myeloma too.

The expert witnesses of the plaintiffs were two toxicologists and an epidemiologist. Toxicology is the science that studies how a chemical can be harmful and how exposure to it can cause illness. Epidemiology studies the causes and effects of exposure to chemicals, for example, myeloma. This is done by studying medical records and statistics.

Treatment

The treatment for myeloma has been focused on radiation and chemotherapy. There are a variety of chemotherapy drugs available. There is also a brand new class of drugs called monoclonal antibodies that can destroy myeloma cells. These include daratumumab and elotuzumab. Combined therapy with these drugs improves outcomes. Other treatments include transplants, stem cells, immunotherapies and the use of cellular vaccines.

Myeloma is an illness that can affect anyone at any age. However, certain circumstances can increase the risk. The older 45 are more at risk, as are people who have an ancestral history of multiple myeloma. People who have come into contact with chemicals or radiation have a higher risk. People who have been exposed to X-rays as well as those who worked in industries that used herbicides such as benzene asbestos or Agent Orange, Csx Transportation Reactive Airway Disease are at an increased risk.

Ronald Harris died of multiple myeloma in the year 2013. His estate filed a lawsuit against csx transportation throat cancer Transportation, claiming that his railroad work was the cause of his cancer. The trial court granted an evidentiary hearing, and heard the testimony of the plaintiff's three scientific experts such as Dr. Goldstein, Dr. Infante and Dr. Durie. They used proven methods to demonstrate that csx transportation leukemia diesel exhaust fumes exposure resulted in Harris' myeloma. The expert witness testimony was based on human studies as well as animal studies, the chemical composition and closely related pyrogenic material of diesel exhaust and tests with B lymphocytes.

Prognosis

Multiple myeloma is an illness that affects plasma cells. These cells are essential to the immune system since they aid the body to fight off diseases and infections. Plasma cells are constantly growing and can obstruct normal bone marrow in myeloma patients. This can cause other health issues such as low blood counts and damage to bones.

Certain risk factors increase a person's chances of developing multiple myeloma. These include the age of the person, family history as well as exposure to radiation or certain chemicals. A first-degree relative suffering from multiple myeloma is twice as likely to get it themselves. Myeloma is also more prevalent among blacks than white people.

Ronald Harris worked for csx transportation esophageal cancer csx transportation copd for 29 years as a trainman for the railroad. He was constantly exposed to diesel exhaust from locomotives. During his employment, Harris was diagnosed with multiple myeloma. a type of cancer that targets plasma cells in the bone marrow. Harris brought a lawsuit under the Federal Employers' Liability Act and Locomotive Inspection Act against csx transportation aplastic anemia. Unfortunately, Harris died while the case was in the midst of being resolved. Deborah Kay Harris became the plaintiff following Harris's death.

The petitioner engaged Dr. Peter Shields as an expert witness in the trial. During the two-day trial, both experts provided evidence on their background and the method they used to render their opinions. Both experts rely on the Bradford Hill methodology.